Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
Study of Cetuximab to Treat Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1